# Actuate Therapeutics, Inc.: Form S-1/A, filed Oct 14, 2026

- Company: [Actuate Therapeutics, Inc.](/companies/actu.md) (CIK 1652935)
- Form: S-1/A
- Filed: 2026-10-14
- Accepted by EDGAR: Oct 14, 2026, 08:01 ET
- Period: not reported
- Accession: 0001683168-26-007832
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1652935/000168316826007832/actuate_s1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1652935/000168316826007832/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1652935/000168316826007832/actuate_s1a.htm

Filed Oct 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001683168-26-007832. Last ingested by Listed: Nov 2, 2026, 18:06 ET. No prices; not investment advice.